Trial
NCT01282047
Lenalidomide in Kaposi Disease Associated With HIV Infection
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
French National Agency for Research on AIDS and Viral Hepatitis
Collaborators
Celgene
Condition
HIV Infection Associated Kaposi Disease
Intervention
Lenalidomide
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-03